Results 191 to 200 of about 80,158 (218)

Photo‐responsive carbon dots for pyroptosis‐mediated anti‐tumor application

Responsive Materials, EarlyView.
Photo‐responsive CDs generate ROS to induce tumor cell pyroptosis, thereby stimulating antitumor immunity. Abstract Pyroptosis refers to a kind of lytic programmed cell death, characterized by the release of pro‐inflammatory cytokines during the process. Owing to its immune response stimulation ability, pyroptosis has garnered considerable attention in
Lingyun Li, Xue Wu, Zekun Yan, Jun Wu, Caishi Huang, Songnan Qu   +5 more
wiley   +1 more source

Chimeric Antibody Engineering Against <i>Bacillus anthracis</i> Lethal Toxin: Neutralization Efficacy and Mechanism of Action. [PDF]

Toxins (Basel)
Kalmantaeva OV, Marin MA, Ershova AA, Ryabko AK, Romanenko YO, Kombarova TI, Dyatlov IA, Firstova VV.   +7 more
europepmc   +1 more source

Editorial: Interdisciplinary innovations in CAR T-cell therapy for autoimmune and cancer treatment. [PDF]

Front Immunol
Zaravinos A, Unutmaz D, Radic M.
europepmc   +1 more source

Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions

Med Research, EarlyView.
Zhiwu Dong, Sixiang Yan, Xiaodong Liu, Peng Gu   +3 more
wiley   +1 more source

Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma. [PDF]

JCO Clin Cancer Inform
Malek E, Betts B, Herr M, Davila M, Holtan S, Driscoll JJ, Yu H.   +6 more
europepmc   +1 more source

Sialic acid <i>cis</i>-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. [PDF]

Oncoimmunology
van Eck van der Sluijs J, Valk AHC, van Houtum EJH, Kers-Rebel ED, Looman M, Hobo W, Marneth AE, Dolstra H, van den Boogaard L, Büll C, Cornelissen LAM, Adema GJ.   +11 more
europepmc   +1 more source

Generation of therapeutic T cells from human induced pluripotent stem cells. [PDF]

Inflamm Regen
Wang B, Kaneko S.
europepmc   +1 more source

To modify or not to modify: Rethinking mRNA design for CAR T cell engineering. [PDF]

Mol Ther Nucleic Acids
Thatte AS, Mitchell MJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Boll, Sandrine Valadè   +2 more
exaly